1. Home
  2. NGVT vs KLRA Comparison

NGVT vs KLRA Comparison

Compare NGVT & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingevity Corporation

NGVT

Ingevity Corporation

HOLD

Current Price

$71.47

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$12.89

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NGVT
KLRA
Founded
1964
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
NGVT
KLRA
Price
$71.47
$12.89
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$72.50
N/A
AVG Volume (30 Days)
186.6K
780.3K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
61.10
N/A
EPS
2.67
N/A
Revenue
$1,167,600,000.00
N/A
Revenue This Year
$3.63
N/A
Revenue Next Year
$0.50
N/A
P/E Ratio
$25.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.85
$11.84
52 Week High
$79.29
$23.82

Technical Indicators

Market Signals
Indicator
NGVT
KLRA
Relative Strength Index (RSI) 51.39 30.66
Support Level $68.24 N/A
Resistance Level $70.69 $19.15
Average True Range (ATR) 1.81 0.97
MACD 0.27 -0.23
Stochastic Oscillator 75.90 12.45

Price Performance

Historical Comparison
NGVT
KLRA

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: